Mutual of America Capital Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-18,010
Closed -$4.25M – 1258
2015
Q1
$4.25M Buy
18,010
+2,284
+15% +$488K 0.09% 296
2014
Q4
$2.98M Buy
15,726
+15,676
+31,352% +$3.48M 0.07% 474
2014
Q3
$12K Buy
+50
New +$10.3K ﹤0.01% 1251

Other funds holding PBYI

Mutual of America Capital Management's PBYI Position: Q2 2015 in Review

Mutual of America Capital Management sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 18,010 shares — an estimated $4.25M sold.

Mutual of America Capital Management first reported a position in PBYI in Q3 2014 and held it in 3 quarters. The position peaked at $4.25M in Q1 2015. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • Mutual of America Capital Management reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • Mutual of America Capital Management sold 18,010 Puma Biotechnology shares in Q2 2015, an estimated $4.25M.
  • Mutual of America Capital Management first reported a position in Puma Biotechnology in Q3 2014 and held it in 3 quarters.
  • Mutual of America Capital Management's Puma Biotechnology position peaked at $4.25M in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Mutual of America Capital Management's 13F filing for Q2 2015, filed 5 Aug 2015.